Pirfenidone for IPF: pro/con debate; the 'con' viewpoint

被引：8
|
作者：
Raghu, Ganesh [1 ]
Thickett, David R. [2 ]
机构：
[1] Univ Washington, Div Pulm & Crit Care Med, Scleroderma Clin, UW Med Ctr, Seattle, WA 98195 USA
[2] Univ Birmingham, Ctr Translat Inflammat & Fibrosis Res, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England
来源：
THORAX | 2013年 / 68卷 / 07期
关键词：
IDIOPATHIC PULMONARY-FIBROSIS; INTERSTITIAL PNEUMONIA; CONTROLLED-TRIAL; DISEASE; INHIBITOR; REPAIR;
D O I：
10.1136/thoraxjnl-2011-201269
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：605 / 608
页数：4
相关论文
共 50 条
  • [31] Long term efficacy of pirfenidone therapy in patients with idiopathic pulmonary fibrosis (IPF)
    Takaiwa, Takuya
    Tachibana, Hiromasa
    Arita, Machiko
    Ishida, Tadashi
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [32] Pirfenidone in idiopathic pulmonary fibrosis (IPF): Early single centre Irish experience
    Barry, Peter
    Murphy, Lorna
    Tuohy, Majella
    Judge, Eoin
    Egan, Jim
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [33] Comparison of Pirfenidone and Nintedanib Post Hoc Analysis of the CleanUP-IPF Study
    Kim, John S.
    Murray, Susan
    Yow, Eric
    Anstrom, Kevin J.
    Kim, Hyun J.
    Flaherty, Kevin R.
    Martinez, Fernando J.
    Noth, Imre
    CHEST, 2024, 165 (05) : 1163 - 1173
  • [34] Con: The Case for Expanded Lung Cancer Research Support
    Geraci, Mark W.
    Keith, Robert L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (11) : 1234 - 1236
  • [35] Chimney stove intervention - ready for scale up? CON
    Mortimer, Kevin
    THORAX, 2016, 71 (05) : 391 - 392
  • [36] Con: Robotic Surgery Is Not the Preferred Technique for Coronary Revascularization
    Raiten, Jesse Michael
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2013, 27 (04) : 806 - 808
  • [37] Cerebral Salt Wasting Is a Real Cause of Hyponatremia: CON
    Sterns, Richard H.
    Rondon-Berrios, Helbert
    KIDNEY360, 2023, 4 (04): : E441 - E444
  • [38] Long term efficacy of pirfenidone therapy in patients with idiopathic pulmonary fibrosis (IPF)
    Takaiwa, Takuya
    Tachibana, Hiromasa
    Arita, Machiko
    Ishida, Tadashi
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [39] Pirfenidone (PFD) effect on morbidity and mortality in patients with idiopathic pulmonary fibrosis (IPF)
    Noble, Paul W.
    Albera, Carlo
    Bradford, Williamson Z.
    Costabel, Ulrich
    du Bois, Roland M.
    Fishman, Robert S.
    Glaspole, Ian
    Glassberg, Marilyn K.
    Lancaster, Lisa
    Lederer, David
    Leff, Jonathan A.
    Nathan, Steven D.
    Pereira, Carlos A.
    Swigris, Jeffrey J.
    Valeyre, Dominique
    King, Talmadge E.
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [40] Long-term safety of combination therapy with nintedanib and pirfenidone in Japanese patients with IPF
    Taniguchi, Hiroyuki
    Ogura, Takashi
    Inoue, Yoshikazu
    Akimoto, Manabu
    Azuma, Arata
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
12345